Office Headquarters: (610) 544-3500

perirx log in button

PeriRx Logo


Get News and Updates



CLIA: 39D2085645

PeriRx on Facebook PeriRx on YouTube PeriRx on Google+ Stephen M. Swanick LinkedIn


New York State has a separate and unique regulatory approval process for laboratory diagnostic testing. PeriRx is currently in the application process with our SaliMark™ OSCC test and is vigorously committed to pursuing this application approval. 

NCI Awards Yale $11M to Fund Lung Cancer Research Program

Genomeweb  logoThe National Cancer Institute has awarded Yale University a five-year, $11 million grant to establish a new research program to study the biology and personalized treatment of lung cancer. The so-called Specialized Program of Research Excellence, or SPORE, initiative is specifically focused on developing novel therapeutics and personalized prevention strategies by improving the understanding of targetable biochemical and immunological pathways involved in the progression of lung cancer and the acquisition of resistance to therapy, according to the grant’s abstract. [Read more…]